Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Helse Nord-Trøndelag HF | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
This pilot study aims to assess patient satisfaction and preliminary efficacy of a psychoeducational group treatment, using a randomized waitlist-controlled trial, at two different outpatient clinics in mid-Norway. All participants will receive standard treatment during the intervention period. Assessment of client satisfaction (CSQ 8), general self-efficacy (GSE-6), ADHD-related quality of life (AAQoL) symptoms of ADHD (SCL-9; ASRS), and work participation will be conducted at time of recruitment prior to randomization (T0), pre- (T1), post-treatment (T2), with a 10 week follow-up.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| psychoeducational groups | Experimental | Psychoeducational group therapy and standard treatment (ADHD treatment as usual) |
|
| Waiting list | Active Comparator | Waiting list and standard treatment (ADHD treatment as usual) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Psychoeducational group therapy | Behavioral | The group-based psychoeducational program consists of 10 sessions, run over 10 consecutive weeks. Each session consist of a lecture, given by a recruited expert on the topic of the session (20 minutes) with a following discussion of the topic (45 minutes), facilitated by the course leader. All sessions are organized and led by the course leader, which also includes keeping structure in time, discussion and closing of the session. Psychoeducation comes in addition to standard treatment (ADHD treatment as usual). |
| Measure | Description | Time Frame |
|---|---|---|
| Change in patient satisfaction | Measured with a modified version of the Client Satisfaction Questionnaire (CSQ-8). The scale consists of 8 items measured on a scale from 1 to 4. A sum score between 8 and 32 indicate the level of satisfaction with services provided. | Baseline, post-intervention (10 weeks) and after 10 weeks follow-up (20 weeks) |
| Change in general self-efficacy | Measured with General Self-Efficacy Scale (GSE-6), a short-form measure of self-efficacy. Self-efficacy is regarded as a protective factor in adapting to stress and chronic illness. The scale consists of 6 items, measured on a 4-point scale, with a possible range of 6-24. | Baseline, post-intervention (10 weeks) and after 10 weeks follow-up (20 weeks) |
| Measure | Description | Time Frame |
|---|---|---|
| Change in ADHD-related symptoms (ASRS) | Measured with ASRS, a self-reporting scale for ADHD-related symptoms in adults. The scale consists of 18 items, based on DSM-V diagnostic criteria for ADHD. The items are measured on a 5-point scale, with a possible range of 0-72. | Baseline, post-intervention (10 weeks) and after 10 weeks follow-up (20 weeks) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Terje Torgersen, phd | St. Olavs Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Levanger Hospital, Nord-Trøndelag Hospital Trust | Levanger | N-T | Norway | |||
| Tiller DPS - St. Olavs University Hospital |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 30693097 | Background | Vaag JR, Lara-Cabrera ML, Hjemdal O, Gjervan B, Torgersen T. Psychoeducational groups versus waitlist in treatment of attention-deficit hyperactivity/impulsivity disorder (ADHD) in adults: a protocol for a pilot randomized waitlist-controlled multicenter trial. Pilot Feasibility Stud. 2019 Jan 23;5:17. doi: 10.1186/s40814-019-0401-1. eCollection 2019. | |
| 41088068 |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001289 | Attention Deficit Disorder with Hyperactivity |
| ID | Term |
|---|---|
| D019958 | Attention Deficit and Disruptive Behavior Disorders |
| D065886 | Neurodevelopmental Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
| ID | Term |
|---|---|
| D014850 | Waiting Lists |
| D013812 | Therapeutics |
| ID | Term |
|---|---|
| D001071 | Appointments and Schedules |
| D009934 | Organization and Administration |
| D006298 | Health Services Administration |
Not provided
Not provided
a Norwegian multicenter study
Not provided
Not provided
Not provided
Not provided
|
| Waiting list | Behavioral | Waiting list and standard treatment (ADHD treatment as usual) |
|
| Standard treatment | Other | Standard treatment consists of diagnostic assessment of ADHD and comorbidity, as well as treatment with medication. In addition, some patients receive cognitive behavioral therapy, although this is not systematically given to every patient. If needed, patients are also offered assistance with regard to economy, housing, education and work. As well as contact with family and network. |
|
|
| Change in ADHD-related symptoms (SCL-9) | Measured with 9 items from the SCL-90. SCL-9 is an ADHD-specific scale, consisting of 9 items of the original 90. SCL-9 covers the specific characteristic traits of ADHD. | Baseline, post-intervention (10 weeks) and after 10 weeks follow-up (20 weeks) |
| Change in ADHD-related quality of life | Measured with AAQoL - which covers ADHD-specific quality of life and function. AAQoL consists of 29 questions measuring health related quality of life among adults with ADHD. | Baseline, post-intervention (10 weeks) and after 10 weeks follow-up (20 weeks) |
| Trondheim |
| S-T |
| 7040 |
| Norway |
| Holsbrekken A, Skliarova T, Mandahl A, Saether SG, Lund AGS, Surkovic J, Sondenaa E, Vaag J, Torgersen T, Lara-Cabrera ML. Effects of a psychoeducational group intervention for adults diagnosed with ADHD: a pilot randomized controlled study. BMC Psychiatry. 2025 Oct 14;25(1):983. doi: 10.1186/s12888-025-07452-5. |